Table S1.
Parameter | B | Standard error | t | Significance |
---|---|---|---|---|
Intercept | −3.554 | 2.112 | −1.682 | 0.096 |
Age | −0.012 | 0.033 | −0.361 | 0.719 |
Gender | ||||
Male | 0.234 | 0.64 | 0.366 | 0.715 |
Female | 0a | |||
Inhaled corticosteroids | ||||
Inhaled corticosteroid use | 0.736 | 0.818 | 0.9 | 0.371 |
No inhaled corticosteroid use | 0a | |||
Smoking status | ||||
Yes | 0.952 | 0.632 | 1.506 | 0.136 |
No (ex-smoker or never-smoker) | 0a | |||
COPD status | ||||
COPD III–IV | 2.37 | 1.173 | 2.02 | 0.047 |
COPD II | 0.256 | 0.719 | 0.356 | 0.723 |
Without COPD | 0a |
Notes:
Reference parameter is set to 0. Linear regression analysis, where the natural logarithm of the mRNA expression of BPIFA1 is designated as the dependent variable; gender as a fixed factor; COPD status, smoking status, and inhaled corticosteroids as random factors; and age as a covariate.
Abbreviation: COPD, chronic obstructive pulmonary disease.